tert-Butyl (R)-(1-methylpiperidin-3-yl)carbamate

Catalog No. :
ACWYKS409
CAS No. :
1001354-56-8
Molecular Formula :
C11H22N2O2
Molecular Weight :
214.31

IUPAC Name:tert-butyl (R)-(1-methylpiperidin-3-yl)carbamate

tert-Butyl (R)-(1-methylpiperidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$67.00Login to see priceInquiryInquiry
1g95%$142.00Login to see priceInquiryInquiry
5g95%$465.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (R)-(1-methylpiperidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(1-methylpiperidin-3-yl)carbamate
MDL No.MFCD28402661
Molecular FormulaC11H22N2O2
Molecular Weight214.31
SMILESCN1CCC[C@H](C1)NC(=O)OC(C)(C)C
InChI KeyRKSXBNIWPXOYBC-SECBINFHSA-N
Synonymtert-Butyl N-[(3R)-1-methylpiperidin-3-yl]carbamate;Carbamic acid, N-[(3R)-1-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester;1,1-Dimethylethyl N-[(3R)-1-methyl-3-piperidinyl]carbamate;Tert-butyl (R)-(1-methylpiperidin-3-yl)carbamate
CAS No.1001354-56-8

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWYKS409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCEVX352 route compound structure diagram
    ACCEVX3521001353-92-9 In Stock
  2. Then
  3. ACWYKS409 route product structure diagram
    ACWYKS4091001354-56-8
Inquiry

2. ACWYKS409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHFCJ831 route compound structure diagram
    ACHFCJ831309956-78-3 In Stock
  4. Then
  5. ACWYKS409 route product structure diagram
    ACWYKS4091001354-56-8
Inquiry

Comments (0)